Search research articles
Contact Us
Filters
Showing results (171-180 of 184) with videos related to
Page
of 19
Sort By:
The Lancet. Oncology
|
April 1, 2024
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2026
Amivantamab in recurrent/metastatic HNSCC after checkpoint inhibitor and chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study
Barbara Burtness, Ari J Rosenberg, Benoit Calderon, et al.
Lancet (London, England)
|
November 20, 2018
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L Gillison, Andy M Trotti, Jonathan Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer
Mitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Mucosal melanoma of the head and neck
David G Pfister, Kie-Kian Ang, David M Brizel, et al.
JAMA Oncology
|
September 28, 2023
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial
Stuart J Wong, Pedro A Torres-Saavedra, Nabil F Saba, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
Benjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
Sri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
David Adelstein, Maura L Gillison, David G Pfister, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2015
Head and Neck Cancers, Version 1.2015
David G Pfister, Sharon Spencer, David M Brizel, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 184) with videos related to
Sort By:
Page
of 19
The Lancet. Oncology
|
April 1, 2024
Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial
Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 31, 2026
Amivantamab in recurrent/metastatic HNSCC after checkpoint inhibitor and chemotherapy: pivotal results from the phase 1b/2 OrigAMI-4 study
Barbara Burtness, Ari J Rosenberg, Benoit Calderon, et al.
Lancet (London, England)
|
November 20, 2018
Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial
Maura L Gillison, Andy M Trotti, Jonathan Harris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2025
Postoperative Radiotherapy ± Cetuximab for Intermediate-Risk Head and Neck Cancer
Mitchell Machtay, Pedro A Torres-Saavedra, Wade Thorstad, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 7, 2012
Mucosal melanoma of the head and neck
David G Pfister, Kie-Kian Ang, David M Brizel, et al.
JAMA Oncology
|
September 28, 2023
Radiotherapy Plus Cisplatin With or Without Lapatinib for Non-Human Papillomavirus Head and Neck Carcinoma: A Phase 2 Randomized Clinical Trial
Stuart J Wong, Pedro A Torres-Saavedra, Nabil F Saba, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 30, 2021
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group
Benjamin Lacas, Alexandra Carmel, Cécile Landais, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 1, 2026
Development of a Clinical Assay to Guide Patient Therapy in HPV-Associated Head and Neck Cancer
Sri Vemulamanda, Aditi Kothari, Loris De Cecco, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
June 10, 2017
NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017
David Adelstein, Maura L Gillison, David G Pfister, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 8, 2015
Head and Neck Cancers, Version 1.2015
David G Pfister, Sharon Spencer, David M Brizel, et al.
Page
of 19